Hospital
Hernando Hma LLC
Hernando Hma LLC was paid $5.85M by Medicaid between Jan 2018 and Oct 2023, across 138 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.
33Billing provider infoHERNANDO HMA LLC
SPRING HILL, FL 34609
SPRING HILL, FL 34609
33aNPI1003847047assigned 07/06/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.85M
24GClaims261,070
24DCodes billed138
24AFirst – last monthJan 2018 – Oct 2023
Compared with peers
Next to other General Acute Care Hospital providers in Florida
Rank by total paid#75 of 163
Median peer was paid$4.77M
This provider vs. median1.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 14,607 | $289K | |
| 2019 | 54,744 | $812K | |
| 2020 | 45,649 | $612K | |
| 2021 | 56,535 | $1.31M | |
| 2022 | 60,529 | $1.89M | |
| 2023 | 29,006 | $939K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 17,884 | 16,183 | $1.37M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 14% | 12,658 | 11,117 | $816K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9.4% | 2,481 | 2,236 | $549K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 8.3% | 5,370 | 4,948 | $485K |
| 70450 | Computed tomography, head or brain; without contrast material | 6.2% | 2,935 | 2,504 | $363K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.8% | 1,510 | 1,350 | $280K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.2% | 3,879 | 3,297 | $247K |
| 96361 | Intravenous infusion, hydration; each additional hour | 3.9% | 4,694 | 4,021 | $229K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.2% | 2,713 | 2,519 | $190K |
| 36415 | Collection of venous blood by venipuncture | 3.0% | 18,720 | 13,269 | $178K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.4% | 3,359 | 3,024 | $138K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.2% | 3,803 | 3,325 | $71K |
126 more codes
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1.1% | 3,184 | $63K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,465 | $57K |
| 80053 | Comprehensive metabolic panel | <1% | 14,799 | $56K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 808 | $50K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,583 | $45K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,071 | $41K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 204 | $35K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,349 | $34K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 415 | $30K |
| G0378 | Hospital observation service, per hour | <1% | 1,586 | $29K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,163 | $27K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,443 | $23K |
| 81001 | <1% | 8,749 | $22K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 499 | $22K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 417 | $20K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 540 | $19K |
| 73630 | <1% | 691 | $16K | |
| 85610 | <1% | 4,810 | $15K | |
| 73610 | <1% | 592 | $15K | |
| 86850 | <1% | 407 | $14K | |
| 71045 | Radiologic examination, chest; single view | <1% | 5,219 | $13K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,476 | $13K |
| 73130 | <1% | 390 | $12K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,056 | $12K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 291 | $12K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 494 | $12K |
| 81003 | <1% | 2,562 | $11K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 382 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,972 | $11K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 4,257 | $10K |
| 86900 | <1% | 994 | $10K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15,002 | $9K |
| 73564 | <1% | 305 | $9K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,476 | $8K |
| 73110 | <1% | 260 | $8K | |
| 76818 | <1% | 90 | $7K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 694 | $7K |
| 87070 | <1% | 247 | $7K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 184 | $6K |
| 84484 | <1% | 3,913 | $6K | |
| 59025 | Fetal non-stress test | <1% | 262 | $6K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,574 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 265 | $5K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 4,791 | $5K |
| 87807 | <1% | 1,656 | $5K | |
| 82962 | <1% | 1,111 | $5K | |
| 84703 | <1% | 1,131 | $4K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 61 | $4K |
| 85730 | <1% | 4,645 | $4K | |
| 87186 | <1% | 1,049 | $4K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 64 | $4K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,790 | $4K |
| 83735 | <1% | 5,298 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,663 | $3K |
| 83690 | <1% | 4,736 | $3K | |
| 73030 | <1% | 178 | $3K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,245 | $3K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 86 | $3K |
| 74018 | <1% | 180 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,216 | $2K |
| 76830 | Ultrasound, transvaginal | <1% | 159 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,186 | $2K |
| 93971 | <1% | 138 | $2K | |
| 86901 | <1% | 1,039 | $2K | |
| 76801 | <1% | 209 | $1K | |
| 83880 | <1% | 1,143 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 319 | $1K |
| 87428 | <1% | 1,438 | $1K | |
| 87210 | <1% | 236 | $984.60 | |
| 85379 | <1% | 1,266 | $915.96 | |
| 72131 | <1% | 29 | $851.99 | |
| 94760 | <1% | 859 | $761.53 | |
| 87077 | <1% | 740 | $750.61 | |
| 87040 | <1% | 1,077 | $670.57 | |
| 70486 | <1% | 12 | $666.98 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,691 | $662.64 |
| 84702 | <1% | 1,235 | $604.99 | |
| 85027 | <1% | 1,485 | $601.65 | |
| 82550 | <1% | 1,187 | $518.70 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 154 | $474.37 |
| 96376 | <1% | 710 | $445.27 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 320 | $418.42 |
| 82077 | <1% | 381 | $400.15 | |
| 93975 | <1% | 13 | $307.34 | |
| 73080 | <1% | 15 | $305.34 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 67 | $227.94 |
| 82553 | <1% | 485 | $195.79 | |
| 81025 | <1% | 2,514 | $166.26 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 414 | $164.48 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,076 | $155.55 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 753 | $153.47 |
| 94664 | <1% | 77 | $143.50 | |
| 87081 | <1% | 2,020 | $104.99 | |
| 87430 | <1% | 2,350 | $104.92 | |
| 83605 | <1% | 232 | $95.30 | |
| 84112 | <1% | 15 | $81.08 | |
| 80143 | <1% | 126 | $78.53 | |
| 80179 | <1% | 85 | $78.53 | |
| 86140 | <1% | 379 | $66.83 | |
| 90714 | <1% | 14 | $65.35 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 26 | $65.35 |
| 72110 | <1% | 13 | $60.64 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 344 | $37.35 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 86 | $21.02 |
| 85651 | <1% | 72 | $8.76 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 450 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 119 | $0.00 |
| 82570 | 0% | 30 | $0.00 | |
| 84156 | 0% | 29 | $0.00 | |
| 29125 | 0% | 13 | $0.00 | |
| 00170 | Anesthesia for intraoral procedures, including biopsy | 0% | 17 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 16 | $0.00 |
| 82150 | 0% | 95 | $0.00 | |
| 73090 | 0% | 13 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 322 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 16 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 258 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 46 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 119 | $0.00 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 15 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 127 | $0.00 |
| 86308 | 0% | 14 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 57 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 43 | $0.00 |
| 88304 | 0% | 16 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.